EMMAHealthcareNano-Cap
Emmaus Life Sciences, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Emmaus Life Sciences, Inc. (EMMA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are EMMA insiders buying or selling?
Emmaus Life Sciences, Inc. insiders reported 171 open-market buys ($3.9M) and 1 sells ($1.6K) across 172 Form 4 filings — a net buying position of $3.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Sep 18, 2024)
Total Form 4 filings
172
SEC EDGAR
Insider filers
6
Insider buys (171)
$3.9M
Insider sells (1)
$1.6K
Insider sentiment
Net buyingNet insider flow of $3.9M in net buying.
Recent EMMA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 18, 2024 | Lim Seah H. | Director | Purchase | 20.0K | $0.04 | $800 |
| Feb 29, 2024 | Willis C Lee | Co-President & COO | Purchase | 115.2K | $0.13 | $14.7K |
| Jan 3, 2024 | Willis C Lee | COO | Purchase | 121.0K | $0.13 | $15.3K |
| Dec 21, 2023 | Lim Seah H. | Director | Sale | 32.5K | $0.05 | $1.6K |
| Dec 20, 2023 | Lim Seah H. | Director | Purchase | 133.2K | $0.23 | $30.3K |
| Dec 5, 2023 | Willis C Lee | COO | Purchase | 15.6K | $0.13 | $2.0K |
| Jun 2, 2023 | Willis C Lee | COO | Purchase | 29.4K | $0.29 | $8.5K |
| Dec 1, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 52.6K | $0.40 | $21.2K |
| Nov 3, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 27.5K | $0.44 | $12.0K |
| Oct 31, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 69.4K | $0.28 | $19.3K |
| Oct 24, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 65.0K | $0.17 | $11.3K |
| Oct 19, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 45.0K | $0.19 | $8.7K |
| Oct 17, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 97.5K | $0.18 | $17.2K |
| Oct 13, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 165.0K | $0.08 | $13.3K |
| Oct 12, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 185.0K | $0.11 | $20.4K |
| Jul 25, 2022 | Willis C Lee | COO | Purchase | 3.2K | $0.39 | $1.2K |
| Jun 3, 2022 | Willis C Lee | Director & COO | Purchase | 5.0K | $0.39 | $1.9K |
| Jun 2, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 7.0K | $0.49 | $3.5K |
| May 19, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 23.4K | $0.41 | $9.6K |
| Apr 12, 2022 | Willis C Lee | Director & COO | Purchase | 15.1K | $0.89 | $13.5K |
| Mar 2, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 53.8K | $1.49 | $80.2K |
| Feb 28, 2022 | Willis C Lee | Vice Chairman & COO | Purchase | 21.1K | $1.49 | $31.5K |
| Feb 28, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 16.5K | $1.42 | $23.5K |
| Feb 23, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 19.3K | $1.44 | $27.8K |
| Feb 18, 2022 | Yutaka Niihara | Chairman and CEO | Purchase | 7.5K | $1.44 | $10.8K |
Showing the 25 most recent of 172 Form 4 filings for Emmaus Life Sciences, Inc..
Most active EMMA insiders
- Yutaka Niihara128 filings
- Willis C Lee32 filings
- Wei Peu Zen5 filings
- John Pappajohn3 filings
- Lim Seah H.3 filings
Ask anything about EMMA insider activity
Use Trabud's AI agent to query Emmaus Life Sciences, Inc.'s Form 4 history in plain English — "Show me EMMA CEO purchases this year" or compare it against any other ticker.
Open the AI agentEMMA insider trading FAQ
Are Emmaus Life Sciences, Inc. insiders buying or selling?
Across 172 SEC Form 4 filings, Emmaus Life Sciences, Inc. (EMMA) insiders reported 171 open-market purchases totaling $3.9M and 1 sales totaling $1.6K. That is a net buying position of $3.9M.
How many insiders trade EMMA stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Emmaus Life Sciences, Inc.. The most recent filing was accepted on Sep 18, 2024.
Where does Trabud get EMMA insider trading data?
All EMMA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.